US regulatory nod for Lupin’s HIV drug in the works
Pharma major Lupin has received a ‘tentative approval’, from the United States Food and Drug Administration (FDA), to market medicines used to treat
Pharma major Lupin has received a ‘tentative approval’, from the United States Food and Drug Administration (FDA), to market medicines used to treat
New research led by Duke researchers says that the SARS Cov-2 virus can make the immune system attack the nerve cells in the
Skipping meals and eating meals too closely together may be linked with increased cardiovascular or mortality, researchers report.
The USFDA has granted Zydus Lifesciences Limited ‘tentative approval’ to market Levomilnacipran extended-release capsules in 20 mg, 40 mg, 80 mg, and 120
The Indian pharmaceutical industry is expected to witness “decent growth” during the three-month period through 31 March 2023, mainly led by continued traction
Eiasi Co., a Japanese pharmaceutical company, has submitted a marketing authorization application for a drug, lacanemab, to treat Alzheimer's disease.
he current treatment of cortical malformations in the anterior parts of the brain, or cerebrum, in vertebrates by its surgical removal to cure
An artificial intelligence-powered machine can reduce the treatment time for stroke patients by 60 minutes and free up clinicians’ time.
The American Academy of Pediatrics has issued guidelines advising aggressive treatment of obesity in children as young as 12.